Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5319
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÇalgüneri, M.-
dc.contributor.authorÇobankara, Veli-
dc.contributor.authorÖzath, D.-
dc.contributor.authorGüler, G.-
dc.contributor.authorApraş, Ş.-
dc.contributor.authorPay, S.-
dc.contributor.authorKiraz, S.-
dc.date.accessioned2019-08-16T11:44:41Z
dc.date.available2019-08-16T11:44:41Z
dc.date.issued2003-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://hdl.handle.net/11499/5319-
dc.identifier.urihttps://doi.org/10.3349/ymj.2003.44.1.155-
dc.description.abstractGiant cell arteritis (GCA) is a common systemic vasculitis with an unknown etiology. It mainly affects people older than 50 years of age and often presents with symptoms such as headache, jaw claudication, visual loss, polymyalgia rheumatica and increased erythrocyte sedimentation rate (ESR). Established blindness is irreversible if the steroid treatment is not administered within a few days. Here, we report a case of GCA in a patient with a normal ESR whose left eye perceived just light at the initiation of treatment. Immediately prior to the combined treatment with high dose oral steroids and cyclophosphamide, the ESR level had increased to 80 mm/h and the vision improved after the combined treatment four months later.en_US
dc.language.isoenen_US
dc.publisherYonsei University College of Medicineen_US
dc.relation.ispartofYonsei Medical Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCyclophosphamideen_US
dc.subjectSteroidsen_US
dc.subjectTemporal arteritisen_US
dc.subjectcyclophosphamideen_US
dc.subjectsteroiden_US
dc.subjectadulten_US
dc.subjectageen_US
dc.subjectarticleen_US
dc.subjectcase reporten_US
dc.subjectclaudicationen_US
dc.subjectdrug megadoseen_US
dc.subjecterythrocyte sedimentation rateen_US
dc.subjectgiant cell arteritisen_US
dc.subjectheadacheen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjecthuman tissueen_US
dc.subjectjaw diseaseen_US
dc.subjectmaleen_US
dc.subjectrheumatic polymyalgiaen_US
dc.subjectsteroid therapyen_US
dc.subjectsymptomatologyen_US
dc.subjectsystemic vasculitisen_US
dc.subjecttimeen_US
dc.subjecttreatment outcomeen_US
dc.subjectvisionen_US
dc.subjectvisual impairmenten_US
dc.titleIn visual loss due to giant cell arteritis reversible?en_US
dc.typeArticleen_US
dc.identifier.volume44en_US
dc.identifier.issue1en_US
dc.identifier.startpage155
dc.identifier.startpage155en_US
dc.identifier.endpage158en_US
dc.identifier.doi10.3349/ymj.2003.44.1.155-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid12619191en_US
dc.identifier.scopus2-s2.0-0037298096en_US
dc.identifier.wosWOS:000181483400024en_US
dc.identifier.scopusqualityQ2-
dc.ownerPamukkale_University-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.openairetypeArticle-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File SizeFormat 
ymj-44-155.pdf556.6 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

7
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

4
checked on Nov 16, 2024

Page view(s)

36
checked on Aug 24, 2024

Download(s)

14
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.